Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

JPMorgan Chase & Co (NY: JPM )

225.19 -2.71 (-1.19%)
Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about JPMorgan Chase & Co

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
99 100 Next >
3 Stocks Helping to Bring AI to Healthcare
Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Stocks soared in 2024, and 2025 could be even stronger. Let's look at key trends, government policies, and sectors poised for growth in the year ahead. 
Via MarketBeat
Topics Economy Energy
Exposures Economy Fossil Fuels Interest Rates
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
$NRXP: Completion of NDA Filing Expected in First Quarter of 2025MIAMI - Dec. 30, 2024 - PRLog -- Developing NRX-101, an FDA-Designated Investigational Breakthrough Therapy for Suicidal... 
Via PRLog
Exposures Product Safety
Dow Jones 2024 Scoreboard: Top 5 Winners, Losers — And How Amazon, Nvidia Could Reshape 2025
Several of the worst performing 2024 Dow Jones stocks won't be included in returns in 2025. A look at the best and worst performers and what's ahead. 
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500 Earnings Set to Shine: January's Critical Market Test
The analysts expect S&P 500 earnings growth to accelerate in Q4 and be led by the financials, including JPMorgan Chase & Company. 
Via MarketBeat
Topics Economy Stocks
Exposures Economy Interest Rates US Equities
OS Therapies Partners With B2i Digital to Engage With Biotech Investors Online
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
'Zelle Became A Gold Mine For Fraudsters': Consumer Financial Protection Bureau Lawsuit
Last week, the Consumer Financial Protection Bureau sued 3 of the nation's largest banks and the operator of Zelle for failing to protect consumers from widespread fraud on the peer-to-peer payment... 
Via Benzinga
Topics Fraud Lawsuit
Exposures Financial Legal
Banks And Business Groups Challenge Fed's Stress Test Rules
Major US banks sue Federal Reserve over lack of transparency in stress testing, claiming opaque processes create volatile capital requirements. 
Via Benzinga
Topics Economy
Exposures Interest Rates
The Year of Concentration, Crypto, China
2024 was another stellar year for investors, but a lot of money is piling into the same places in the U.S. and globally. 
Via The Motley Fool
Is Stock Market Open Or Closed On Christmas Day 2024? Here Is What You Can Trade Today
U.S. financial markets will observe the Christmas holiday with modified trading hours, marking a brief pause in what has been an eventful year for Wall Street. 
Via Benzinga
Introducing the "Dividend Seven" Stocks
Via The Motley Fool
It's a Sporting Time of Year. Time to Take a Look at Academy Sports and Outdoors.
We also answer listener questions about diversification in the S&P 500. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
"Motley Fool Money" Looks Back at Financials Stocks in 2024
It's been a banner year for banks. Even the worst performer among the big players is up 40% year-to-date. 
Via The Motley Fool
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at JP Morgan 2025 Annual Healthcare Conference
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Warren Buffett Recommends This Index Fund. It Could Turn $500 Per Month Into $968,900
Via The Motley Fool
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb. 
Via Benzinga
3 Stocks That Could Join the Trillion-Dollar Market Cap Club Next Year
Via The Motley Fool
Here's My Only Major Concern With Archer Aviation
Via The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Right Now
Passive income requires solid companies and a solid underlying industry. Here are some top names that fit both bills. 
Via The Motley Fool
Missed Out on Nvidia: 1 No-Brainer Artificial Intelligence (AI) Stock to Buy Before It Crushes the Market in 2025, and Beyond
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Kilroy Realty Stock Flew Higher on Friday
Via The Motley Fool
Defensive Oil Stocks To Watch In 2025 Amid $70 Brent Forecast: JP Morgan
JP Morgan analyst updates ratings, price targets, and forecasts for major North American oil companies. Brent crude expected to average ~$70/bbl in 2025, with focus on defensive positioning and unique... 
Via Benzinga
4 Dividend Picks For 2025: JPMorgan's Top Income Stocks To Energize Your Portfolio
JPMorgan analysts recommend 4 income stocks for 2025: NLY, GLW, ET, HASI. Annaly offers 13.85% yield, Corning has AI potential, Energy Transfer undervalued, HASI focuses on sustainability. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Spot Market Trends With These 3 Must-Watch ETFs
There are major divergences and convergences in different ETFs today, which investors need to consider for their portfolios. 
Via MarketBeat
Topics Bonds ETFs Economy
Exposures Debt Markets Economy Interest Rates
J.P. Morgan Wealth Management Ranks #1 in J.D. Power Digital Experience Study
From JPMorgan Chase & Co.
Via Business Wire
21% of Warren Buffett's "Secret" Portfolio Is Invested in These 3 ETFs. Are They Great Picks for 2025?
Via The Motley Fool
Topics ETFs
Billionaire Israel Englander Sells Apple Stock and Buys an Index Fund That Could Soar 180%, According to a Wall Street Analyst
Via The Motley Fool
Streamers Max, Paramount+ Won November: Here's Why Analyst Expects Netflix, Amazon To Win December
JPMorgan analysts pick the winners for the streaming sector in November based on downloads and user activity and look ahead to December. 
Via Benzinga
Who's Next To Join Tesla, Broadcom In $1 Trillion Club? Over 50% Say The World's Biggest Retailer
A Benzinga reader poll finds which company could be the next to join the $1 trillion market capitalization club after Broadcom. 
Via Benzinga
Match Group Analyst Flags Tinder Woes, Industry Challenges For Stock Downgrade
JPMorgan downgrades Match Group from Overweight to Neutral, lowers target to $33. Reflects muted growth, limited Tinder turnaround, undemanding valuation, dividends and buybacks. 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.